Showing results (1231-1240 of 1,244) with videos related to

Sort By:
Pageof 125
The Lancet. Neurology|January 10, 2021
Comparison of eight prehospital stroke scales to detect intracranial large-vessel occlusion in suspected stroke (PRESTO): a prospective observational studyMartijne H C Duvekot, Esmee Venema, Anouk D Rozeman, et al.
Stroke|July 19, 2023
Comparison of Prehospital Assessment by Paramedics and In-Hospital Assessment by Physicians in Suspected Stroke Patients: Results From 2 Prospective Cohort StudiesLuuk Dekker, Jasper D Daems, Martijne H C Duvekot, et al.
Blood Cancer Journal|June 19, 2023
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabineJacobien R Hilberink, Isabelle A van Zeventer, Dana A Chitu, et al.
The Lancet. Haematology|November 1, 2023
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trialMichael Lübbert, Pierre W Wijermans, Michal Kicinski, et al.
Stroke|July 16, 2021
Prediction of Outcome and Endovascular Treatment Benefit: Validation and Update of the MR PREDICTS Decision ToolEsmee Venema, Bob Roozenbeek, Maxim J H L Mulder, et al.
Stroke|September 20, 2021
Blood Pressure in the First 6 Hours Following Endovascular Treatment for Ischemic Stroke Is Associated With OutcomeNoor Samuels, Rob A van de Graaf, Carlijn A L van den Berg, et al.
Prehospital Emergency Care|May 23, 2023
Prehospital Stroke Triage: A Modeling Study on the Impact of Triage Tools in Different RegionsMartijne H C Duvekot, Bjarty L Garcia, Luuk Dekker, et al.
Blood Advances|December 9, 2021
Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trialAnita W Rijneveld, Bronno van der Holt, Okke de Weerdt, et al.
Cancers|February 10, 2021
Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDSJeroen Janssen, Bob Löwenberg, Markus Manz, et al.
The Lancet. Neurology|September 4, 2022
Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trialSophie A van den Berg, Simone M Uniken Venema, Hendrik Reinink, et al.
Pageof 125